Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991: An age-period-cohort analysis

Brain

Volumn 119, Issue 1, 1996, Pages 203-211

  Midgard, Rune ^a,b   Riise, Trond ^a   Svanes, Cecilie ^a   Kvåle, Gunnar ^a   Nyland, Harald ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b Molde County Hospital   (Norway)

Author keywords

Age period cohort analysis; Epidemiology; Incidence; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NORWAY; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NORWAY; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0029979662     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.1.203     Document Type: Article

References (45)

1. Benedikz JEG, Magnusson H, Poser CM, Gudmundsson G. Multiple sclerosis in Iceland 1 January 1900-31 December 1989: 90 years total population study. In: Lauer K, Firnhaber W, editors. Multiple sclerosis in Europe - an epidemiological update. Alsbach/Bergstrasse: Leuchtturm-Verlag, 1994: 41-50.
2. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 1987a; 6: 449-67.
3. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 1987b; 6: 469-81.
4. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980; 103: 281-300.
5. Cook SD, Cromarty JI, Tapp W, Poskanzer D, Walker JD, Dowling PC. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35: 545-51.
6. Cook SD, MacDonald J, Tapp W, Poskanzer D, Dowling PC. Multiple sclerosis in the Shetland Islands: an update. Acta Neurol Scand 1988; 77: 148-51.
7. Dixon WJ, Brown MB, Engelman L, Jennrich RI. BMDP Statistical Software Manual. Berkeley: University of California Press, 1990.
8. EGRET. Seattle: Statistics and Epidemiology Research Corp, 1990.
9. Grønning M, Mellgren SI. Multiple sclerosis in the two northernmost counties of Norway. Acta Neurol Scand 1985; 72: 321-7.
10. Grønning M, Riise T, Kvåle G, Nyland H, Larsen JP, Aarli JA. Incidence of multiple sclerosis in Hordaland, Western Norway: a fluctuating pattern. Neuroepidemiology 1991; 10: 53-61.
11. Hader WJ, Elliot M, Ebers GC. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology 1988; 38: 617-21.
12. Hillert J, Grønning M, Nyland H, Link H, Olerup O. An immunogenetic heterogeneity in multiple sclerosis. J Neurol Neurosurg Psychiatry 1992; 55: 887-90.
13. Holford TR. The estimation of age, period and cohort-effects for vital rates. Biometrics 1983; 39: 311-24.
14. Kinnunen E. Multiple sclerosis in Finland: evidence of increasing frequency and uneven geographic distribution. Neurology 1984; 34: 457-61.
15. Koch-Henriksen N, Brönnum-Hansen H, Hyllested K. Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study. Neuroepidemiology 1992; 11: 1-10.
16. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS. Neurology 1986; 36: 307-28.
17. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics. Acta Neurol Scand 1987; 76: 317-39.
18. Kurtzke JF, Gudmundsson KR, Bergmann S. Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic. Neurology 1982; 32: 143-50.
19. Kurtzke JF, Hyllested K, Heltberg A, Olsen A. Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission [published erratum appears in Acta Neurol Scand 1994; 90: 303]. Acta Neurol Scand 1993; 88: 161-73.
20. Larsen JP, Kvåle G, Ruse T, Nyland H, Aarli JA. An increase in the incidence of multiple sclerosis in Western Norway. Acta Neurol Scand 1984; 70: 96-103.
21. Larsen JP, Kvåle G, Ruse T, Nyland H, Aarli JA. Multiple sclerosis: more than one disease? Acta Neurol Scand 1985; 72: 145-50.
22. Lauer K, Firnhaber W. editors. Multiple sclerosis in Europe - an epidemiological update. Alsbach/Bergstrasse: Leuchtturm-Verlag, 1994.
23. Martyn C. The epidemiology of multiple sclerosis. In: Matthews WB, Compston A, Allen IV, Martyn CN, editors. McAlpine's multiple sclerosis. 2nd ed. Edinburgh: Churchill Livingstone, 1991: 3-40.
24. Matthews WB. Symptoms and signs. In: Matthews WB, Acheson ED, Batchelor JR, Weller RO, editors. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone. 1985: 96-145.
25. McAlpine D. The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain 1961; 84: 186-203.
26. Meyer-Rienecker H, Buddenhagen F. Incidence of multiple sclerosis: a periodic or stable phenomenon. J Neurol 1988; 235: 241-4.
27. Midgard R, Ruse T, Nyland H. Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology 1991; 41: 887-92.
28. Minderhoud JM, Zwanikken CP. Increasing prevalence and incidence of multiple sclerosis: an epidemiological study in the province of Groningen, the Netherlands. In: Lauer K, Firnhaber W, editors. Multiple sclerosis in Europe - an epidemiological update. Alsbach/Bergstrasse: Leuchtturm-Verlag, 1994; 113-21.
29. Percy AK, Nobrega FT, Okazaki H, Glattre E, Kurland LT. Multiple sclerosis in Rochester, Minn. A 60-year appraisal. Arch Neurol 1971; 25: 105-11.
30. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north-east (Grampian Region) of Scotland - an update. J Epidemiol Community Health 1987; 41: 5-13.
31. Poser CM, Hibberd PL, Benedikz J, Gudmundsson G. Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects. Neuroepidemiology 1988; 7: 168-80.
32. Poser S, Scheidt P, Kitze B, Lüer W, Schafer U, Nordmann B. Impact of magnetic resonance imaging (MRI) on the epidemiology of MS. Acta Neurol Scand 1991; 83: 172-5.
33. Poskanzer DC, Prenney LB, Sheridan JL, Kondy JY. Multiple sclerosis in the Orkney and Shetland Islands. I: epidemiology, clinical factors, and methodology. J Epidemiol Community Health 1980; 34: 229-39.
34. Presthus J. Multiple sclerosis in Møre og Romsdal County, Norway. Acta Neurol Scand 1966; 42 Suppl 19: 12-18.
35. Rosati G, Aiello I, Mannu L, Pirastru MI, Agnetti V, Sau G, et al. Incidence of multiple sclerosis in the town of Sassari, Sardinia, 1965 to 1985: evidence for increasing occurrence of the disease. Neurology 1988; 38: 384-8.
36. Statistics Norway. Statistical Yearbook. Vital Statistics. County. 1992; 111; 58.
37. Stazio A, Paddison RM, Kurland LT. Multiple sclerosis in New Orleans. Louisiana, and Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and comparison between the patient population in the two communities. J Chronic Dis 1967; 20: 311-32.
38. Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Am Neurol Scand 1990; 82: 161-8.
39. Swank RL, Lerstad O, Strøm A, Backer J. Multiple sclerosis in rural Norway. N Engl J Med 1952; 246: 721-8.
40. Van Lambalgen R, Sanders EACM, D'Amaro J. Sex distribution, age of onset and HLA profiles in two types of multiple sclerosis: a role for sex hormones and microbial infections in the development of autoimmunity? J Neurol Sci 1986; 76: 13-21.
41. Waterhouse J, Muir C, Correa P, Powell J. Cancer incidence in five continents. Vol. 3. IARC Scientific Publications No. 15. Lyon: International Agency for Research on Cancer, 1976.
42. Wikström J, Tienari PJ, Sumelahti ML, Hovi E, Kinnunen E, Palo J. Multiple sclerosis in Finland: evidence of uneven geographic distribution, increasing frequency and high familial occurrence. In: Lauer K, Firnhaber W, editors. Multiple sclerosis in Europe - an epidemiological update. Alsbach/ Bergstrasse: Leuchtturm-Verlag, 1994: 73-8.
43. Williams ES, Jones DR, McKeran RO. Mortality rates from multiple sclerosis: geographical and temporal variations revisited. J Neurol Neurosurg Psychiatry 1991; 54: 104-9.
44. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota [see comments]. Neurology 1990; 40: 780-6. Comment in: Neurology 1991; 41: 157-8.
45. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota [see comments]. Neurology 1990; 40: 780-6. Comment in: Neurology 1991; 41: 157-8.